Study: Costs associated with neonatal abstinence syndrome significant

05/8/2013 | Medscape (free registration)

Treatment costs for infants with abstinence syndrome at one hospital amounted to $4 million over three years, according to a study presented at a meeting of the American Society of Addiction Medicine. The study looked specifically at children whose mothers received opioid replacement therapy.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC